Abstract. The endothelial differentiation of stem cells serves an essential role in vascular development, function and disease. Autograft adipose-derived stem cells (ADSCs) may be a novel source of cell for use in the study of angiogenesis. microRNA-126 (miR-126) has been extensively studied in endothelial cells. However, the effect of miR-126 on the endothelial differentiation of ADSCs has not been demonstrated. In the present study, it was observed that the expression of miR-126 was markedly increased during the endothelial differentiation of ADSCs in a time-dependent manner. The effect of miR-126 on ADSC differentiation was confirmed by employing up-and down-regulation strategies. The expression of endothelial markers was decreased by miR-126 inhibitor transfection during endothelial differentiation. The results of the present study suggest that miR-126 is essential for endothelial phenotype expression, and may promote the progress of endothelial differentiation in ADSCs, providing a novel strategy for modulating vascular formation and function.
Introduction
Due to the rapid development of stem cell transplantation in preclinical research and clinical trials over the last decade, stem cell replacement therapies have become modern therapeutic approaches (1) . Similar to bone-marrow stromal cells, adipose-derived stem cells (ADSCs) have the ability to differentiate into various types of cell lineage, including adipogenic, osteogenic, myogenic and chondrogenic cells (2, 3) . In addition, the yield of mesenchymal stem cells (MSCs) from adipose tissue is 100-500 fold that from bone marrow (4) . The unique biology of autologous ADSCs, including being easily expanded, immune-privileged and capable of long-term transgene expression following multiple stages of differentiation, demonstrates their potential as a gene delivery vehicle (5) (6) (7) .
The endothelial differentiation of ADSCs serves an essential role in vascular development, function and disease (8) . Numerous peptide growth factors promote angiogenesis by promoting differentiation, and enhancing endothelial cell proliferation, migration and capillary network stability (9) .
The knockdown of microRNA-126 (miR-126) in zebrafish in vivo resulted in the loss of vascular integrity and hemorrhage during embryonic development, and targeted deletion of miR-126 in mice caused delayed angiogenic sprouting, widespread hemorrhaging and partial embryonic lethality (10) (11) (12) . These vascular abnormalities may be attributed to diminished angiogenic growth factor signaling, resulting in reduced endothelial cell differentiation, growth, sprouting and adhesion (13) (14) (15) (16) . This evidence indicates that miR-126 may be involved in multiple aspects of fundamental biological processes, including angiogenesis. However, the role of miR-126 in mediating the differentiation of ADSCs to endothelial cells has not been demonstrated.
The present study focused on the association between miR-126 and the endothelial differentiation of ADSCs.
Materials and methods

Cell growth curve and endothelial differentiation of ADSCs.
ADSCs were purchased from the American Type Culture Collection (Manassas, VA, USA) and cultured in α-Minimum Essential Medium (α-MEM; Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA), supplemented with 10% fetal bovine serum (Gibco; Thermo Fisher Scientific, Inc.) at 37˚C in 5% CO 2 . Equal numbers (2x10 4 ) of passage (p)1, 3, 6 and 8 cells were plated and cultured. Cells images were obtained at x100 magnification using a phase-contrast inverted light microscope. Cells were harvested each day for 8 days. The total number of cells was counted in each plate using a hemocytometer. The cell growth curve was drawn by plotting the mean cell number of each plate against the culture time. For endothelial differentiation, ADSCs were cultured in Endothelial Cell Growth Medium-2 (EGM-2; Lonza, Basel, Switzerland). 100; CWBiotech, Beijing, China) for 3 h at room temperature, the cells were counterstained by incubation with DAPI (Sigma-Aldrich, Merck KGaA). Images were obtained at magnification x200 using a phase contrast fluorescence microscope (Olympus Corporation, Tokyo, Japan).
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
Total RNA and miRNA were isolated using a miRNeasy Mini kit (Qiagen, Inc., Valencia, CA, USA). Synthesis of complementary DNA from mRNA and miRNA was performed using a PrimeScript RT reagent kit (Takara Bio, Inc., Otsu, Japan) or a miRcute miRNA First-Strand cDNA Synthesis kit (Tiangen Biotech Co., Ltd., Beijing, China), respectively. RT-qPCR analysis of mRNA and miRNA was performed using SYBR Premix Ex Taq™ (Takara Bio, Inc.) or a miRcute miRNA qPCR Detection kit (SYBR Green) (Tiangen Biotech Co., Ltd.), respectively. Amplification data was recorded using an ABI 7500 Real-Time PCR System (Applied Biosystems; Thermo Fisher Scientific, Inc.). The PCR analysis of miR-126 consisted of 38 cycles of 95˚C for 15 sec and 60˚C for 1 min, following an initial denaturation step of 95˚C for 10 min. The expression level of miR-126 was normalized to U6 small nuclear RNA, and the expression levels of CD31, vWF and eNOS mRNA were normalized to GAPDH. The primers used are presented in Table I . The results were subjected to melting curve analysis, and the data were analyzed using the 2 -ΔΔCq method (17) . 
Results
Morphological features of cultured ADSCs.
The ADSCs attached to the culture dish surface exhibited a typical fibroblast-like morphology. The cells were maintained in culture with no sign of senescence or differentiation following repeated subculturing to p6 (Fig. 1A-C) . In order to investigate whether passages affect cell growth, the number of cells was recorded every day for 8 days and compared with the cell growth curve of p1, 3, 6 and 8. Following an initial lag or stationary period (day 1), the cells expanded rapidly in a logarithmic manner until a plateau was reached (day 6). However, the ADSCs exhibited markedly more rapid growth at p3 and 6 (Fig. 1D) .
Endothelial phenotype during endothelial differentiation in ADSCs. ADSCs were subjected to incubation in EGM-2 to stimulate endothelial differentiation. When cultured in medium with endothelial cell growth supplement, ADSCs expressed endothelial-specific markers, including CD31, vWF and eNOS (Fig. 2) . These endothelial markers were rapidly upregulated during differentiation and remained elevated 14 days post-differentiation (data not shown).
Differential expression of miR-126 during endothelial differentiation of ADSCs.
The non-induced and endothelial-induced ADSCs were harvested on days 0, 7 and 14, and analyzed for miR-126 level using RT-qPCR analysis, to determine the expression of miR-126 at the different stages of endothelial differentiation. It was identified that the expression of miR-126 was enriched in HUVECs and markedly increased during the endothelial differentiation of ADSCs in a time-dependent manner (Fig. 3A) .
Transfection of ADSCs. In order to study the effect of miR-126 in the endothelial differentiation of ADSCs, a miR-126 overexpression and inhibition model was established. After 24 h, transfection efficiency was detected by Cy3-siRNA transfection control (siR-Rib). Following transfection with miR-126 mimic or inhibitor for 3 days, the expression of miR-126 was detected to assess the efficiency of overexpression and inhibition (Fig. 3B) .
miR-126 modulates the endothelial phenotype of ADSCs.
The expression of CD31, vWF and eNOS largely mirrored that of endothelial markers during endothelialization. The expression of these markers was decreased by miR-126 inhibitor transfection during endothelial differentiation at the mRNA (Fig. 4 ) and protein level (Fig. 5) . In addition, ADSCs with miR-126 overexpression were generated through transfection of a miR-126 mimic. It was identified that the expression of endothelial markers was not notably affected by miR-126 overexpression.
Discussion
ADSCs may be easily harvested from lipoaspirate and the extraction maybe less invasive and less expensive compared with extraction from bone marrow. Additionally, ADSCs have a significantly shorter doubling time when expanded in vitro (18) . In the present study, ADSCs of p3-6were used for the experiments and it was observed that the majority of the cells exhibited typical fibroblastoid morphology, expressed MSC surface markers, and demonstrated the capability for multipotency (data not shown). These intrinsic characteristics and advantages make ADSCs an ideal stem cell source for the present study and future cell-based tissue engineering and therapies (19, 20) . In the present study, expression analyses revealed an abundant level of miR-126 in HUVECs and identified miR-126 as one of the miRs known to be specifically expressed in the endothelial cell lineage. Expression of miR-126 gradually increased during ADSC endothelial differentiation, and expression was marked when endothelial markers were expressed. Endothelial differentiation markers (CD31, vWF and eNOS) were used to evaluate the differentiation capability of ADSCs. The results of the present study suggest that miR-126 may be involved in the directional differentiation of ADSCs into vascular endothelial cells, and may promote the progress of the differentiation.
Due to the high expression of miR-126 in HUVECs, and the increased expression during the endothelial differentiation of ADSCs, the potential role of this miR in the regulation of differentiation towards the endothelial lineage was investigated. In order to confirm the role of miR-126 in the endothelial differentiation of ADSCs, down-and up-regulation of miR-126 expression was achieved through transfection withmiR-126 inhibitor and mimic, respectively. As a result of miR-126 inhibition in ADSCs undergoing the endothelial differentiation, diminished mRNA expression of endothelial cell markers was observed. These results demonstrated that the downregulation of miR-126 may exhibit a negative effect on endothelial differentiation. By contrast, the overexpression of miR-126 did not improve the expression levels of endothelial markers. The results of the present study suggest that while miR-126 is enriched in vascular endothelial cells, and is essential to endothelial differentiation, it is not sufficient to promote the differentiation of ADSCs towards an endothelial phenotype.
Previous research has demonstrated that miR-126 serves an essential role in stem cell differentiation (21) and angiogenesis. However, the mechanism remains unknown and there is a lack of consistency between studies. It is difficult to connect the physiological functions of miR-126 in vasculature to its functions in tumor. It has been established that angiogenesis represents one of the key features in the pathogenesis of cancer (22) , but little is known about the role of miR-126 in tumor neoangiogenesis. The present study suggests that miR-126 may have a supportive role in the progression of cancer, which maybe mediated by the promotion of blood vessel growth. By contrast, it was reported that the downregulation of miR-126 increased the activity of vascular endothelial growth factor-A in lung and breast cancer (23) (24) (25) . miR-126 is regarded as a putative tumor suppressor due to its potential role in anti-angiogenesis in cancer (26) . Consequently, miR-126 may function differently in stromal cells compared with tumor cells. The effect and mechanism of miR-126 on angiogenesis in different cells or tissue requires further research, to compare the effects of miR-126 in tumor cells with the functions of miR-126 in tumor vasculature and the surrounding vessels of the tumor periphery.
